Previous 10 | Next 10 |
Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that the Company will host a conference call and webcast on ...
Gainers: Immunic (NASDAQ: IMUX ) +48% . Soliton (NASDAQ: SOLY ) +17% . Biomerica (NASDAQ: BMRA ) +14% . Foresight Autonomous Holdings (NASDAQ: FRSX ) +13% . Cemtrex (NASDAQ: CETX ) +12% . Verastem (NASDAQ: VSTM ) +11% . Cigna Corporation (NYSE: CI ) +11% . Mastech Digital (NYS...
Verastem (NASDAQ: VSTM ) +3.8% pre-market after presenting supportive Phase 1 clinical data for duvelisib (Copiktra) in patients with relapsed or refractory peripheral T-cell lymphoma at International Conference on Malignant Lymphoma currently underway in Switzerland. More news on: Ver...
Steven Horwitz, MD, Gives Oral Presentation Highlighting Phase 1 Duvelisib Data in Patients with Relapsed or Refractory PTCL Data from Two Phase 1 Studies Show Response Rates of 44-57%, Including Complete Response Rates of 15-22% Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology o...
Verastem's (NASDAQ: VSTM ) President and Chief Executive Officer (CEO), Robert Forrester has decided to step down from his position. More news on: Verastem, Inc., Healthcare stocks news, Read more ...
Robert Forrester Stepping Down From His Roles as President and Chief Executive Officer Chief Operating Officer, Dan Paterson Appointed President Chief Financial Officer, Rob Gagnon, Expanding Role to Include Chief Business Officer Verastem, Inc. (Nasdaq: VSTM) (Verastem Onco...
Recently in the journal Nature , an article was published characterizing the oldest known example of a fungus. The organism, termed an Ourasphaira, was approximately one billion years old and was found in what was believed to be an ancient river bed in Canada. For comparison sake, the oldes...
Gainers: Sotheby's (NYSE: BID ) +58% . Array BioPharma (NASDAQ: ARRY ) +57% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +42% . Vislink Technologies (NASDAQ: VISL ) +40% . MTech Acquisition (NASDAQ: MTEC ) +34% . Endurance International Group Holdings (NASDAQ: EIGI ) +26% . C&am...
In CLL/SLL Patients in the DUO Study, Duvelisib Treatment Rapidly Increased Lymphocytes and Resulted in Shrinkage of Lymph Nodes, With 86% of Patients Achieving a Lymph Node Response Dose Modifications Utilized in the DUO Study May Be Used to Manage Adverse Events for CLL/SLL Patients ...
Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that the Company will present at the Jefferies 2019 Global Healthcare Conference on Fri...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock and accompanying warrants to purchase up to 13,333,334 shares of it...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock, as well as pre-funded warrants t...